Table 3.
Effect of adipokines on MDA levels in pregnant women according to gestational weight gain
| B | 95% CI | p value | R2/(R2 adjusted) | |
|---|---|---|---|---|
| AWG | ||||
| Constant | 102 | 2.48–202 | 0.045 | |
| Adiponectin | 1.85 | −1.16 to 4.86 | 0.211 | 0.233 (0.090) |
| Leptin | 0.836 | −0.264 to 1.94 | 0.127 | |
| Resistin | −1.15 | −3.83 to 1.52 | 0.375 | |
| IWG | ||||
| Constant | 257 | 176–339 | <0.0001 | |
| Adiponectin | −1.10 | −3.73 to 1.53 | 0.398 | 0.302 (0.211) |
| Leptin | −2.15 | −3.83 to −0.466 | 0.015 | |
| Resistin | −1.60 | −4.61 to 1.41 | 0.283 | |
| EWG | ||||
| Constant | 164 | 94.0–235 | <0.0001 | |
| Adiponectin | 0.996 | −3.65 to 5.64 | 0.659 | 0.435 (0.350) |
| Leptin | 0.956 | 0.345–1.57 | 0.004 | |
| Resistin | −2.42 | −4.80 to 0.044 | 0.046 |
Models included 74 pregnant women; adequate weight gain (AWG) (n = 20), insufficient weight gain (IWG) (n = 28), and excessive weight gain (EWG) (n = 26). MDA, malondialdehyde.